Wiscon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 10-12-2024
- Paid Up Capital ₹ 1.50 M
as on 10-12-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.55 Cr
as on 10-12-2024
- Satisfied Charges ₹ 11.25 Cr
as on 10-12-2024
- Revenue -19.16%
(FY 2021)
- Profit -4.60%
(FY 2021)
- Ebitda 12.10%
(FY 2021)
- Net Worth 47.42%
(FY 2021)
- Total Assets -32.70%
(FY 2021)
About Wiscon Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.55 Cr. The company has closed loans amounting to ₹11.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakeshkumar Patel and Kartik Parikh serve as directors at the Company.
- CIN/LLPIN
U74900MH2007PTC286130
- Company No.
286130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wiscon Pharmaceuticals Private Limited offer?
Wiscon Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Pain Balm & Ointments, Health Care Service, Medical Care Services, Cough Syrup.
Who are the key members and board of directors at Wiscon Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kartik Parikh  | Managing Director | 22-Feb-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakeshkumar Patel | Director | 18-Jun-2015 | Current |
Financial Performance of Wiscon Pharmaceuticals.
Wiscon Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 19.16% decrease. The company also saw a slight decrease in profitability, with a 4.6% decrease in profit. The company's net worth Soared by an impressive increase of 47.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wiscon Pharmaceuticals?
In 2021, Wiscon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 11 May 2023 | ₹3.50 Cr | Open |
Others Creation Date: 14 Feb 2022 | ₹0.45 M | Open |
Bank Of Baroda Creation Date: 16 Jan 2008 | ₹11.25 Cr | Satisfied |
How Many Employees Work at Wiscon Pharmaceuticals?
Wiscon Pharmaceuticals has a workforce of 33 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wiscon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wiscon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
